The prognostic and diagnostic markers of invasive candidiasis in patients during chemotherapy

• Autorzy: Magrys A , Koziol-Montewka M. , Staroslawska E. , Gabczynska B.
• Języki publikacji: EN

Abstrakty

EN

The aim of the work was the early detection of Candida spp. in clinical samples of patients with carcinoma ovariorum undergoing chemotherapy by comparing three indicators of candidiasis: presence of mannan and yeast DNA in the bloodstream and colonization of mucosal membranes by Candida species as a prognostic marker of deep candidiasis. Thirty-one women with carcinoma ovariorum, during chemotherapy without symptoms of deep fungal infections, were examined twice over a six-day period. C. albicans was the dominant organism isolated from mucosal membranes. Two serum samples were positive for mannan on the first day of examination. All these patients were previously colonized by Candida spp. on mucous membranes. Four patients were positive on the last day of examination. Three of these patients were colonized by Candida spp. C. albicans infection was detected early in 4 out of 12 clinical samples by a combination of PCR and mannan-detecting methods. Colonization increases the risk of deep candidiasis. PCR and antigen detection are fast and reliable methods for early detection of Candida in bloodstream. For patients at risk, the clinical samples must be tested by at least two independent methods.

Słowa kluczowe

EN

chemotherapy; patient; candidiasis; Candida albicans; Candida; clinical microbiology; cancer; detection

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2005
• Tom: 54
• Numer: 3
• Opis fizyczny: p.207-213,ref.

Twórcy

autor

Magrys A

• Medical University, Chodzki 1, 20-123 Lublin, Poland

autor

Koziol-Montewka M.

autor

Staroslawska E.

autor

Gabczynska B.

Bibliografia

• Abbas J., G.P. Bodey and H.A. Hanna. 2000 Candida krusei fungemia: an escalating serious infection in immunocompromised patients. Arch. Intern. Med. 160: 2659-2664.
• Buchman T.G., M. Rossier, W. Merz and P. Charache. 1990. Detection of surgical pathogens by in vitro DNA amplification. Part I. Rapid identification of Candida albicans by in vitro amplification of a fungus-specific gene. Surgery 108: 338-347.
• Elie C.H., T.J. Lott, E. Reiss and C.J. Morrison. 1998. Rapid identification of Candida species with species-specific DNA probes. J. Clin. Microbiol. 36: 3260-3265.
• Flahaut M., D. Sang lad, M. Mouod, J. Bille and M. Rossier. 1998. Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes. J. Clin. Microbiol. 36: 395-401.
• Füsle R. 1997. Diagnosis of fungal infections. Mycoses 40 (Supp). 2): 13-15.
• Holmes A.R., R.D. Cannon, M.G. Sheperd and H.P. Jenkinson. 1994. Detection of Candida albicans and other yeasts in blood by PCR. J. Clin. Microbol. 32: 228-231.
• Kwok S. and R. Higuchi. 1989. Avoiding false positives with PCR. Nature (London) 339: 237-238.
• Morgenstern G.R., A.G. Prentice, H.G. Prentice, J.E. Ropner, S.A. Schey and D.W. Warnock. 1999. A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignances. Br. J. Haemathol. 105: 901-911.
• Murray RR., E.J. Baron, M.A. Pfaller, F.C. Tenover and R.H. Yolken. 1999. Manual of clinical microbiology. 7th Edition, ASM Press, Washington 1184-1241.
• Pagano L., A. Antionori and A. Ammassiari. 1999. Retrospective study of candidemia in patients with haematological malignances. Clinical features, risk factors and outcome of 76 episodes. Eur. J. Haematol. 63: 77-85.
• Pfaller M.A. 1995. Epidemiology of candidiasis. J. Hosp. Inf. 30 (Suppl): 329-338.
• Richardson M.D. and M.H. Kokki. 1999. New perspectives in the diagnosis of systemic fungal infections. Ann Med. 31: 327-335.
• Rüchel R. 1997. Clinical presentation of invasive Candida mycoses. Mycoses 40 (Suppl. 2): 17-20.
• Safdar A., V. Chaturvedi, E.W. Cross, S. Park, E.M. Bernard, D. Armstrong and D.S. Perlin. 2001. Prospective study of Candida species in patients at a comprehensive cancer center. Antimicrob. Agents Chemother. 45: 2129-213.
• Sendid B., M. Tabauret, J.L. Poirot, D. Mathien, J. Fruit and D. Paulain. 1999. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systematic candidiasis. J. Clin. Microbiol. 37: 1510-1517.
• Shin J.H., F.S. Nolte and C.J. Morrison. 1997. Rapid identification of Candida species in blood cultures by a clinically useful PCR method. J. Clin. Microbiol. 36: 1454-1459.
• Shin J.H., F.S. Nolte, B.P Holloway and C.J. Morrison. 1999. Rapid identification of up to three Candida species in a single reaction tube by a 5' exonuclease assay using fluorescent DNA probes. J. Clin. Microbiol. 37: 165-170.
• Yamamura D.L.R., C. Rotstein, L.E. Nicolle and S. Ioannou. 1999. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Can. Med. Assoc. J. 160: 493-499.
• Yeo S.F. and B. Wong. 2002. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin. Microbiol. Rev. 15: 465-484.